Physician profile
Ali Merhe
NPI 1356961593
$8,427.50
in general payments reported to CMS, 2019-2025
8 companies · $1,532 in 2025
The $1,532 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $266 · 2023: $2,720 · 2024: $3,910 · 2025: $1,532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Travel and Lodging: $2,710 · Debt Forgiveness: $1,500 · Food and Beverage: $929 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Travel and Lodging | $2,710.38 |
| Debt Forgiveness | $1,500.00 |
| Food and Beverage | $928.64 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,876.02 | 2023-2025 | Da Vinci Surgical System |
| Boston Scientific Corporation | $1,050.28 | 2023 | Moses 550 D\F\L, Lithovue |
| Photocure INC | $265.64 | 2022 | |
| Teleflex LLC | $96.65 | 2023 | Urolift |
| Conmed Corporation | $47.83 | 2023 | Airseal |
| W. L. Gore & Associates, INC. | $36.85 | 2024 | Gore Synecor Biomaterial |
| 180 Medical, INC. | $31.73 | 2025 | |
| Urogen Pharma, INC. | $22.50 | 2023 | Jelmyto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Merhe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.